JPWO2022186282A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022186282A5 JPWO2022186282A5 JP2023503916A JP2023503916A JPWO2022186282A5 JP WO2022186282 A5 JPWO2022186282 A5 JP WO2022186282A5 JP 2023503916 A JP2023503916 A JP 2023503916A JP 2023503916 A JP2023503916 A JP 2023503916A JP WO2022186282 A5 JPWO2022186282 A5 JP WO2022186282A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- nucleic acid
- viral vector
- diabetes
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021033714 | 2021-03-03 | ||
| JP2021145796 | 2021-09-07 | ||
| PCT/JP2022/008898 WO2022186282A1 (ja) | 2021-03-03 | 2022-03-02 | 糖尿病に対するｈｂ－ｅｇｆ遺伝子治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022186282A1 JPWO2022186282A1 (https=) | 2022-09-09 |
| JPWO2022186282A5 true JPWO2022186282A5 (https=) | 2024-02-08 |
Family
ID=83154306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503916A Pending JPWO2022186282A1 (https=) | 2021-03-03 | 2022-03-02 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240173381A1 (https=) |
| EP (1) | EP4302785A4 (https=) |
| JP (1) | JPWO2022186282A1 (https=) |
| KR (1) | KR20240004273A (https=) |
| AU (1) | AU2022230492A1 (https=) |
| BR (1) | BR112023017808A2 (https=) |
| CA (1) | CA3212726A1 (https=) |
| IL (1) | IL305627A (https=) |
| MX (1) | MX2023010315A (https=) |
| PH (1) | PH12023552425A1 (https=) |
| WO (1) | WO2022186282A1 (https=) |
| ZA (1) | ZA202309227B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2025211357A1 (https=) * | 2024-04-02 | 2025-10-09 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1949907B1 (en) * | 2005-09-28 | 2014-07-02 | Kagoshima University | Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| JP2007223939A (ja) * | 2006-02-22 | 2007-09-06 | Kobe Univ | エネルギー代謝促進因子としてのｈｂ−ｅｇｆの使用 |
| US8236758B2 (en) * | 2007-07-20 | 2012-08-07 | Saitama Medical University | Method of treatment of diabestes or reduction in pancreatic beta-cells |
| JP6711495B1 (ja) | 2019-05-27 | 2020-06-17 | 株式会社ナイスリー | 車両用盗難防止装置 |
| JP2021033714A (ja) | 2019-08-26 | 2021-03-01 | 東芝テック株式会社 | 商品販売データ処理装置及びプログラム |
| JP7040807B2 (ja) | 2020-03-17 | 2022-03-23 | 株式会社オリンピア | 遊技機 |
-
2022
- 2022-03-02 AU AU2022230492A patent/AU2022230492A1/en active Pending
- 2022-03-02 BR BR112023017808A patent/BR112023017808A2/pt unknown
- 2022-03-02 PH PH1/2023/552425A patent/PH12023552425A1/en unknown
- 2022-03-02 JP JP2023503916A patent/JPWO2022186282A1/ja active Pending
- 2022-03-02 CA CA3212726A patent/CA3212726A1/en active Pending
- 2022-03-02 US US18/548,807 patent/US20240173381A1/en active Pending
- 2022-03-02 KR KR1020237033566A patent/KR20240004273A/ko active Pending
- 2022-03-02 IL IL305627A patent/IL305627A/en unknown
- 2022-03-02 WO PCT/JP2022/008898 patent/WO2022186282A1/ja not_active Ceased
- 2022-03-02 MX MX2023010315A patent/MX2023010315A/es unknown
- 2022-03-02 EP EP22761939.2A patent/EP4302785A4/en active Pending
-
2023
- 2023-10-02 ZA ZA2023/09227A patent/ZA202309227B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12409236B2 (en) | Liver-specific nucleic acid regulatory elements and methods and use thereof | |
| US20080254109A1 (en) | Localized myocardial injection method for treating ischemic myocardium | |
| US20040161412A1 (en) | Cell-based VEGF delivery | |
| Bai et al. | Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization | |
| JP2004506658A5 (https=) | ||
| US20180296641A1 (en) | Method to induce neovascular formation and tissue regeneration | |
| JP2007161732A (ja) | 遺伝子転移媒介の血管形成療法 | |
| JP2010070565A5 (https=) | ||
| US20030100889A1 (en) | Method of administration of a gene of interest to a vascular tissue | |
| Ohashi et al. | Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo | |
| JPWO2022186282A5 (https=) | ||
| JP2021533801A5 (https=) | ||
| JP4124565B2 (ja) | インターフェロンβのような分泌タンパク質をコードする遺伝子を使用する治療のための方法および組成物 | |
| JPWO2022107853A5 (https=) | ||
| JPWO2020038473A5 (https=) | ||
| Hirsch et al. | Gene therapy in cutaneous wound healing | |
| CA2266619A1 (en) | Non-invasive administration of adeno-associated viral vectors | |
| JPWO2025211357A5 (https=) | ||
| KR20190082134A (ko) | 유전자 전달용 세포 시트 | |
| US20230414718A1 (en) | Low-dose hepatocyte growth factor gene therapy for diabetes | |
| Shen et al. | Gene Therapy for Stroke | |
| US20210269508A1 (en) | Methods for regulating endogenous production of lactoferrin and sub-peptides thereof | |
| Cyclohydrolase et al. | 1111. Prolonged T 1. Prolonged T 1. Prolonged Transgene Expression in the ransgene Expression in the ransgene Expression in the Arterial Wall Using a Helper-Dependent all Using a Helper-Dependent all Using a Helper-Dependent Adenoviral V Adenoviral V Adenoviral Vector | |
| CN116685340A (zh) | 针对糖尿病的低剂量的肝细胞生长因子基因治疗 | |
| Kitagawa et al. | Future Aspects of Gene Therapy in Acute Ischemic Stroke |